Development Level

Tbio 9 | 11,445
Tchem 6 | 1,598

IMPC Phenotype

increased mean corpuscular vol... 3 | 92
decreased T cell number 2 | 15
decreased vertical activity 2 | 208
abnormal bone mineralization 1 | 38
abnormal bone structure 1 | 187
abnormal heart morphology 1 | 162
abnormal kidney morphology 1 | 65
abnormal liver morphology 1 | 17
abnormal lung morphology 1 | 26
abnormal retina morphology 1 | 71
abnormal sleep behavior 1 | 70
decreased CD4-positive, alpha ... 1 | 7
decreased CD8-positive, alpha-... 1 | 8
decreased IgG1 level 1 | 8
decreased bone mineral density 1 | 126
decreased circulating amylase ... 1 | 28
decreased circulating choleste... 1 | 93
decreased circulating glucose ... 1 | 126
decreased circulating insulin ... 1 | 76
decreased circulating triglyce... 1 | 79
decreased erythrocyte cell num... 1 | 62
decreased monocyte cell number 1 | 8
decreased prepulse inhibition 1 | 82
decreased red blood cell distr... 1 | 41
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
enlarged heart 1 | 210
enlarged lymph nodes 1 | 37
hypoactivity 1 | 132
increased IgG2b level 1 | 1
increased bone mineral content 1 | 108
increased circulating triglyce... 1 | 42
increased fasted circulating g... 1 | 76
increased grip strength 1 | 41
increased lean body mass 1 | 172
increased lymphocyte cell numb... 1 | 32
increased mean corpuscular hem... 1 | 96
increased or absent threshold ... 1 | 101
increased vertical activity 1 | 24
preweaning lethality, complete... 1 | 979
preweaning lethality, incomple... 1 | 499
small seminal vesicle 1 | 10
thrombocytopenia 1 | 56
vertebral fusion 1 | 23

Disease

Cancer 13 | 2,499
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,291
Carcinoma 8 | 11,493
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,989
osteosarcoma 8 | 7,950
malignant mesothelioma 7 | 3,232
ovarian cancer 7 | 8,520
tuberculosis 7 | 2,010
atypical teratoid / rhabdoid tumor 6 | 5,112
diabetes mellitus 6 | 1,728
invasive ductal carcinoma 6 | 2,951
lung adenocarcinoma 6 | 2,716
pancreatic cancer 6 | 2,398
psoriasis 6 | 6,694
Vascular disease 5 | 319
breast carcinoma 5 | 1,638
ductal carcinoma in situ 5 | 1,745
glioblastoma 5 | 5,792
interstitial cystitis 5 | 2,312
lung cancer 5 | 4,740
Bipolar Disorder 4 | 666
Inflammatory bowel disease 4 | 151
Multiple Sclerosis 4 | 540
Rheumatoid arthritis 4 | 1,191
gastric carcinoma 4 | 807
lung carcinoma 4 | 2,843
medulloblastoma, large-cell 4 | 6,241
non-small cell lung cancer 4 | 2,890
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
primary pancreatic ductal adenocarcinoma 4 | 1,109
Ankylosing spondylitis 3 | 140
Atherosclerosis 3 | 291
Atopic dermatitis 3 | 952
Breast Neoplasms 3 | 445
Breast cancer 3 | 3,578
Eye disease 3 | 62
Hypersensitivity reaction type II disease 3 | 253
Increased IgM levels 3 | 16
Kidney disease 3 | 430
Mammary Neoplasms 3 | 425
Obesity 3 | 678
active ulcerative colitis 3 | 764
adult high grade glioma 3 | 3,801
colon cancer 3 | 1,478
cystic fibrosis 3 | 1,696
ependymoma 3 | 4,679
fibroadenoma 3 | 559
pituitary cancer 3 | 1,972
sonic hedgehog group medulloblastoma 3 | 467
subependymal giant cell astrocytoma 3 | 2,287
ulcerative colitis 3 | 1,819
Acquired immunodeficiency syndrome 2 | 197
Allergic hypersensitivity disease 2 | 126
Amyotrophic lateral sclerosis 2 | 451
Arthritis, Rheumatoid 2 | 174
Astrocytoma, Pilocytic 2 | 3,081
Carcinoma, Non-Small-Cell Lung 2 | 107
Common variable immunodeficiency 2 | 101
Coronary artery disease 2 | 268
Dermatitis 2 | 157
Diabetic Angiopathies 2 | 16
Diarrhea 2 | 253
Hepatomegaly 2 | 285
IgG Deficiency 2 | 22
Immunoglobulin A deficiency (disorder) 2 | 19
Immunologic Deficiency Syndromes 2 | 113
Impaired memory B-cell generation 2 | 3
Increased susceptibility to bacterial infections 2 | 42
Influenza 2 | 142
Kidney cancer 2 | 2,613
Leishmaniasis 2 | 47
Leukopenia 2 | 72
Liver Cirrhosis 2 | 181
Liver Cirrhosis, Experimental 2 | 769
Lung Neoplasms 2 | 232
Neutrophil count decreased 2 | 47
Polycystic ovary syndrome 2 | 360
Prone to bacterial infection 2 | 42
Prostatic Neoplasms 2 | 495
Recurrent bacterial infection 2 | 42
Salmonellosis 2 | 42
Schizophrenia 2 | 1,160
Urticaria 2 | 67
Vasculitis 2 | 80
active Crohn's disease 2 | 922
acute quadriplegic myopathy 2 | 1,158
adrenocortical carcinoma 2 | 1,428
astrocytoma 2 | 1,146
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 510
cutaneous lupus erythematosus 2 | 1,057
dermatomyositis 2 | 966
esophageal adenocarcinoma 2 | 737
head and neck cancer 2 | 271
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
hepatocellular carcinoma 2 | 547
nasopharyngeal carcinoma 2 | 1,058
non-small cell lung carcinoma 2 | 317
oligodendroglioma 2 | 2,850
urothelial carcinoma 2 | 318

Tissue

Blood and immune system 15 | 16,909
Cardiovascular System 15 | 15,192
Digestive Tract 15 | 17,369
Endocrine System 15 | 18,159
Female tissues 15 | 17,400
Liver and Pancreas 15 | 16,750
Male tissues 15 | 17,142
Respiratory system 15 | 16,393
Skin and soft tissues 15 | 17,230
Urinary Tract 15 | 16,678
Nervous System 14 | 16,725

Target Family

Non-IDG 9 | 12,091
Transcription Factor 2 | 1,400
Enzyme 1 | 4,145
GPCR 1 | 408
Ion Channel 1 | 344
Kinase 1 | 634

GO Process

positive regulation of endothe... 15 | 15
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
X-box-binding protein 1 XBP1 Tchem Transcription Factor -2.90444 780.2 514
Collagen alpha-1(XVIII) chain COL18A1 Tbio Non-IDG -3.18339 1561.4 433
Endosialin CD248 Tbio Non-IDG -3.07620 1180.8 253
Forkhead box protein O3 FOXO3 Tbio Transcription Factor -2.94477 863.9 864
CD40 ligand CD40LG Tbio Non-IDG -4.58203 37578.3 1461
Programmed cell death protein 4 PDCD4 Tchem Non-IDG -2.50341 321.0 599
Tumor necrosis factor receptor superfamily member 5 CD40 Tchem Non-IDG -3.50040 3120.3 1879
G-protein coupled estrogen receptor 1 GPER1 Tchem GPCR -2.78141 706.4 288
Protein kinase C iota type PRKCI Tchem Kinase -1.71694 51.2 148
Anoctamin-6 ANO6 Tbio Ion Channel -2.50568 319.2 90